NHS National Generics Pharmaceuticals Transition 2023_1
Estimated value
£99.3m
Awarded value
£57.6m
Suppliers
1
Lots
1
Published
24 May 2023
Description
Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1 Offer reference number: CM/PHG/22/5666 FIND A TENDER (FTS) Reference number: 2023/S 000-000801 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. CM/PHG/22/5666/00 - Transition Products: CESW 01/08/2023 - 31/01/2024 (6 months) NWLN 01/08/2023 - 31/01/2025 (18 months) LSNE 01/08/2023 - 31/05/2024 (10 months) CM/PHG/22/5666/01 - Orals (plus non-parenteral) Products: All regions: 01/08/2023 to 31/05/2024 (10 Months)
Scope
- Reference
- CF-1587300D0O000000rwimUAA
- Total value
- £99,290,712 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Jul 2023 to 31 Jan 2025
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 17 Feb 2023, 1:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£57.6m
Award date
04 May 2023
Contract start
31 Jul 2023
Contract end
31 Jan 2025